Advertisement HST Global and Ebitda Capital form strategic alliance - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

HST Global and Ebitda Capital form strategic alliance

HST Global has contracted with Ebitda Capital of Newport Beach California and its group of associates to assist the company's efforts in working toward an overall corporate strategy.

Ron Howell, CEO and president of HST Global retained Ebitda Capital, said: “Through the use of the Ebitda Capital resources we at HST Global can focus on the issue of bringing awareness of our treatment and solution for late stage cancer treatment.

“We want to insure that our treatment is being given every opportunity to be recognized as the medical solution alternative of choice.”